Knight Therapeutics Inc.
CIK 1756235 · View on SEC EDGAR ↗
Insider
First SEC filing: July 29, 2026 · Latest: July 29, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 11, 2025 | SNYR | P | 428,570 | — | — | 428,570 Indirect | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 11, 2025 | SNYR | Pre-Funded Common Stock Purchase Warrant | Common Stock (428,570) | — | — | 428,570 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 29, 2026 | SXTPW | Common Stock, $0.0001 par value per share | 658,629 | Direct |